In accordance with the NMPA approval, Gyre intends to pursue an adaptive Phase 2/3 clinical trial design, combining dose exploration with efficacy confirmation, to efficiently evaluate pirfenidone's ...
"One of the conversations I heard in the hallway was, 'What's going to happen to my research, my data? This is data that [is ...
Like it or not, this is the world we live in, and fact-checking, head-on debate, or claiming the moral high ground are often ...
Val Kilmer kept his throat cancer secret for several years. He died of pneumonia on Tuesday, more than 10 years after his ...
The tests may have been carried out with good intentions but the reality represented some significant oversights, gaffs, and ...
Nuclear weapons can produce some of the most devastating destruction of any device ever created by humankind -- so what ...
Find out about how biotech is done in space through the example of Exobiosphere and its €2 million seed round.
Today, 85% of children with cancer survive to adulthood and about 1 in 3 are left infertile from chemotherapy or radiation.
Company to showcase new Fire-Hazmat innovations at FDIC 2025, Indianapolis, as first EXO 8 Gamma area monitors ship to ...
A new trailer for "Superman" has dropped ... and, it's giving fans a longer look at Krypto the Superdog -- and, a peek inside ...
A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic pontine glioma (DIPG) is safe, reported Weill Cornell Medicine and ...